- Home
- Our People
- Youn-Jin Kim
Many features of this site require JavaScript. Learn how to enable javascript.
Youn-Jin Kim
Senior Associate
Email: ykim@fredlaw.com
Office: 612.492.7106
Assistant: Marian Heinemann, 612.492.7531
Overview
Experience
Honors & Education
Professional Activities
Overview
Youn-Jin’s practice focuses on private equity mergers and acquisitions, strategic mergers and acquisitions, capital raising and exit transactions for private growth companies and other private capital investments.
Youn-Jin has represented national and regional private equity firms, strategic buyers, venture-backed growth companies, domestic and foreign venture capital firms, and public companies in transactions in values ranging from several billion to several million dollars. He helps his clients find practical and cost-effective solutions to various legal and business challenges in transactions.
Experience
REPRESENTATIVE EXPERIENCE
Mergers and Acquisitions
- Represented a leading national middle market private equity firm in its sale of a national designer, marketer and distributor of branded aftermarket wheels to another national private equity firm ($405 million)
- Represented a Minnesota-based IT software company specializing in the areas of system/network management, business intelligence and security in its acquisition of a cybersecurity solution provider from a national private equity firm based in California ($30 million)
- Represented a publicly traded Irish medical device company in its acquisition of a legacy diabetic device business from a leading European medical device maker
- Represented a Bay Area-based private equity firm in its acquisition of a leading manufacturer of lighting control and power distribution products for the motion picture and entertainment industry
- Represented a Bay Area-based private equity firm in its acquisition of a leading manufacturer of aftermarket parts and accessories for the motorcycle and all-terrain vehicle ("ATV") industries
- Represented national middle market private equity firms in more than 20 add-on acquisitions in the last two years
- Represented a publicly traded Dutch medical device company specializing in orthopedic extremity surgical solutions products in its stock-for-stock merger with a publicly traded global medical device/biologics company based in U.S. ($3.3 billion)
- Represented Uroplasty in its stock-for-stock merger with Vision-Sciences ($50 million)
- Represented a privately held company specializing in minimally invasive interventional pulmonology devices in its sale to a publicly traded Irish medical device/pharmaceutical company ($300 million)
- Represented a publicly traded Dutch medical device company specializing in orthopedic extremity surgical solutions products in its acquisition of a lower extremity device company based in U.S. ($135 million plus earnout)
- Represented a publicly traded leading U.S. manufacturer and retailer of air beds in its acquisition of another air bed manufacturer ($15.5 million)
Venture Capital
- Represented a Shanghai-based private equity fund in its investment of $13 million (Series A round) in a Cayman Island holding company that has operations in both Israel and Hong Kong
- Represented a precision pulmonary informatics company in its mid-stage private offering of preferred stock (Series B round) of approximately $5 million
- Represented a medical device company specializing in treatment of chronic diseases related to weak sphincter muscles in late stage private offerings of preferred stock of approximately $30 million (Series D round) and $25 million (Series E round)
- Represented a medical device company developing a minimally invasive device to treat the causes and symptoms of acute decompensated heart failure (ADHF) in an early stage private offering of preferred stock (Series A round) of approximately $20 million
- Represented a medical device company focused on developing new technologies to treat rotator cuff disease in an oversubscribed, mid-stage private offering of preferred stock (Series B round) of approximately $27 million
- Represented a medical device company developing technologies to treat overactive bladders in an early stage private offering of preferred stock (Series A round) of approximately $13 million
- Represented a SaaS company (web-based clinical study and data management service provider) in an early stage private offering of preferred stock (Series A round) of approximately $6 million
- Represented other life science and emerging growth companies in various stages of private offerings, bridge financings and strategic transactions
Honors & Education
EDUCATION
- University of Iowa College of Law, J.D., 2010
- Chungnam National University, LLB, 2001
BAR ADMISSIONS
- Minnesota, 2010
HONORS
- Minnesota State Bar Association, North Star Lawyer, 2017
LANGUAGES
- Korean
Professional Activities
PROFESSIONAL ACTIVITIES
- Hennepin County Bar Association
- Minnesota State Bar Association
- American Bar Association
- Korean American Bar Association - Minnesota
COMMUNITY
- Board member, Downtown YMCA
- Volunteer attorney, LegalCORPS